Dainippon Sumitomo Pharma Co Ltd, 10% Owner at Myovant Sciences Ltd. (MYOV), bought 206,204 shares at $24.83 ($5.3M) on 2021-09-01, disclosed to the SEC on 2021-09-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.83 | 40,000 | $993K | 18.8% |
| 2 | $24.83 | 40,000 | $993K | 18.8% |
| 3 | $25.25 | 22,209 | $561K | 10.6% |
| 4 | $25.25 | 22,209 | $561K | 10.6% |
| 5 | $26.46 | 35,045 | $927K | 17.6% |
| 6 | $26.46 | 35,045 |
| $927K |
| 17.6% |
| 7 | $26.95 | 5,848 | $158K | 3.0% |
| 8 | $26.95 | 5,848 | $158K | 3.0% |
| Total | $25.59 avg | 206,204 | $5.3M | 100% |
| Filing → |
| MYOV | BUY | 2021-08-20 | $2.7M | — | Filing → |
| MYOV | BUY | 2021-08-18 | $3.0M | — | Filing → |
| MYOV | BUY | 2020-05-21 | $1.6M | — | Filing → |